Good scientific practice includes validating results across multiple sources and is vital when using real-world data (RWD) to guide healthcare decision-making. Using two studies that were recently presented at the ISPOR Annual Meeting, members of TriNetX’s clinical sciences department will demonstrate how they used RWD to provide this critical validation.
The first study will illustrate how data from the TriNetX federated network of healthcare organizations (HCOs) around the globe helped advance the effort to streamline the assessment and management of care among patients with polycystic ovary syndrome (PCOS). The second study and publication cited by the FDA, demonstrates the real-world association between fluoroquinolone use and aortic aneurysm.
Please join us to learn more about utilizing RWD for validation of clinical practice recommendations and how combining the data and analytics platform available from TriNetX helped advance this research.
- Jennifer Stacey, Vice President of Clinical Studies, TriNetX
- Seth Kuranz, Epidemiologist, TriNetX